Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMMUNOX: FOLFOX + Immunotherapy with Intrahepatic Oxaliplatin in Liver Metastatic CRC
NCT04430985Phase 2Withdrawn
- Start
- Sep 2020
- Primary completion
- Sep 2021
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of nivolumab, ipilimumab in colorectal cancer (CRC). Planned start Sep 2020; status: withdrawn.
02
Drugs
nivolumabipilimumab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT04430985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04430985.